Xenetic Biosciences (XBIO) Q1 2026 Annual Earnings
XBIO·Reported May 12, 2026·After market close
Xenetic Biosciences reported Q1 2026 revenue of $806.9K (+36.0% YoY). Diluted EPS came in at $-0.20 (+66.1% YoY).
Revenue
$806.9K
Diluted EPS
$-0.20
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Xenetic Biosciences's Q1 2026 earnings report.
Xenetic Biosciences (XBIO) reported Q1 2026 earnings on May 12, 2026 after market close.
Xenetic Biosciences reported revenue of $806.9K and diluted EPS of $-0.20 for Q1 2026.
Compared to the same quarter a year prior, revenue grew 36.0% from $593.3K a year earlier and diluted EPS grew 66.1% from $-0.59.
You can read the 8-K earnings release (0001683168-26-003766) and the 10-K/A periodic report (0001683168-26-003207) directly on SEC EDGAR. The filing index links above go to sec.gov.